Executive Director, Analytics & Insights (NSCLC)

Revolution Medicines•Redwood City, CA

1d•$265,000 - $331,000•Hybrid

About The Position

Revolution Medicines is a late-stage clinical oncology company focused on developing novel targeted therapies for patients with RAS-addicted cancers. The company's pipeline includes several RAS(ON) inhibitors in clinical development. This Executive Director role, reporting to the Vice President, US Analytics & Insights, will lead analytics and insights for the Lung franchise. The position is critical for shaping franchise strategy through data-driven insights, supporting launch planning, commercialization readiness, and collaborating with various internal partners including forecasting, commercial, medical, and market access teams. The leader will act as a player/coach, contributing to strategic analyses while building and developing a high-performing team. Candidates should possess deep oncology expertise, strong leadership, and a proven ability to translate complex data into actionable business insights within a fast-growing organization. The role is based at the company's headquarters in Redwood City, CA.

Requirements

Advanced degree (PhD, PharmD, MD, MBA, or equivalent) in a scientific or business discipline.
12+ years of relevant experience in biotech, pharmaceutical, or consulting environments, consistent with Executive Director-level expectations at RevMed.
Deep experience in oncology.
Demonstrated success supporting product launches and commercialization in oncology.
Strong leadership experience, including building and leading high-performing teams, with a demonstrated ability to operate effectively as a hands-on player/coach.
Expertise in market research, data analytics, and strategic insight generation; ability to translate data into strategy.
Experience working in close partnership with forecasting and finance teams, providing analytical inputs without direct ownership of forecasting.
Excellent communication skills with the ability to influence senior leadership and cross-functional stakeholders.
Strong business acumen and ability to operate effectively in a fast-paced, evolving environment.

Nice To Haves

Strong preference for lung cancer expertise.

Responsibilities

Serve as the franchise lead for Analytics & Insights for Lung, ensuring readiness to support successful launch planning, commercialization, and performance tracking in the US market.
Lead generation of strategic insights from market research and advanced analytics to inform critical business decisions and franchise strategy.
Operate as a player/coach, directly conducting and guiding critical analyses while mentoring team members and establishing best practices across the function.
Partner closely with forecasting, finance, and portfolio strategy teams to provide key inputs, assumptions, and insights that inform forecast development (note: this role does not own forecasting).
Collaborate with global insights & analytics, commercial, medical affairs, and market access teams to define business questions, shape research objectives, and understand evolving market dynamics in lung cancer.
Translate complex datasets into clear, compelling insights and recommendations, and effectively communicate to senior leadership and cross-functional stakeholders.
Oversee the design and execution of primary and secondary market research, including vendor selection and management, ensuring application of best practices and fit-for-purpose methodologies.
Partner with Marketing, Sales, Market Access, and Information Systems to: Define key performance indicators (KPIs) Oversee the development of dashboards and reporting infrastructure Enable data-driven performance monitoring and decision-making
Serve as a strategic thought partner to franchise leadership, identifying key business drivers, risks, and opportunities.
Drive adoption of innovative analytics approaches, including artificial intelligence, advanced analytics, competitive intelligence, and emerging data sources.
Build, lead, and develop a high-performing team supporting the Lung franchise.